ASOP EU comprises a growing number of stakeholders - patient organisations, internet intermediaries, healthcare providers, pharmaceutical companies, and supply chain stakeholders. Your organisation may benefit from becoming a participant. The level of involvement depends on your willingness. The coalition consists of a steering group with three work streams: public awareness (Buyers group), Intermediaries and Policy and Legislation. Much participation is via teleconferencing combined with key face to face meetings (approximately 3 per year). This is a vital area of activity to protect patients’ safety from the rising tide of falsified medicines (counterfeit) across Europe and the World and progress can only be made by a concerted collaborative effort.

If you would like to join ASOP EU then please contact or


Click here for a list of Members and Observers






News from ASOP EU

New scientific article aims to help simplify fake medicine terminology

4 Apr 2017

A new in depth analysis of the evolution of the descriptions applied to falsified, counterfeit and fake medicines has just been published. It aims to help clarify and simplify this hitherto controversial area. With the number of increasing illegally operating websites selling medicines across the world clear and easy to understand descriptors which will help to make public awareness raising campaigns more effective.

ASOP EU member adopts top level domain name .pharmacy

23 Mar 2017

To help ensure absolute security and recognition of a genuine fully legal online seller of medicines, the web page of the European Association of Mail Service Pharmacies (EAMSP) recently became the first in Europe to switch its Top Level Domain to .pharmacy. 

EAASM and ASOP EU to be present at the 22nd Congress of the European Association Of Hospital Pharmacists 22-24 March 2017.

10 Mar 2017

Mike Isles will be speaking on “Falsified Medicines: The Role of the Pharmacist in Raising Patient Awareness.




ASOP EU Members


Web design by Tribal Systems